Results 251 to 260 of about 184,542 (286)

An 11‐Month‐Old Infant With Unusual Diaper Dermatitis

JEADV Clinical Practice, EarlyView.
Majda Chaoui, Léo‐Paul Secco, Ifigenia Spanoudi‐Kitrimi   +2 more
wiley   +1 more source

Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases

Rare Metals, EarlyView.
ABSTRACT Chronic inflammatory skin diseases, encompassing immune‐inflammatory conditions and infection‐associated dermatoses, pose significant clinical challenges due to high prevalence, recurrence, and therapeutic resistance, affect over 30% of the global population.
Zehao Lan, Shengjie Xue, Junyi Yin, Shaolei Wang, Yunlei Zhou, Jieyue Liao   +5 more
wiley   +1 more source

The molecular mechanism of the adverse effects of the biological and small molecular drugs in the therapy of inflammatory skin diseases - psoriasis and atopic dermatitis. [PDF]

Ann Med
Lemiesz P, Nowowiejska-Purpurowicz J, Flisiak I.   +2 more
europepmc   +1 more source

Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Individual Patient Response from the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials

J.Q. Del Rosso, Hwanhee Hong, Leon Kircik, Melinda Gooderham, Mark Lebwohl, Kim Papp, Linda Stein Gold, Adelaide A. Hebert, Melissa Seal, David Krupa, David H. Chu, Patrick Burnett, David R. Berk, Robert Higham   +13 more
openalex   +2 more sources

Managing Monitoring: Biologic Therapy for Psoriasis

JEADV Clinical Practice, EarlyView.
Claudine Howard‐James, Eimear Gilhooley   +1 more
wiley   +1 more source

Alterations of the Gut Microbiome in Psoriasis before and after Treated with Secukinumab.

Indian J Dermatol
Fang L, Cheng S, Zuo C, Zhang L.
europepmc   +1 more source

Long-term management of psoriasis recurrence via modulation of cutaneous microbiome: synergistic topical therapy with blue light and aptamer-functionalized curcumin formulation. [PDF]

Drug Deliv
Jin N, Chen Y, Luo H, Su Y, Weng Y, Lin X, Zheng T, Li B, Liu T, Chen J.   +9 more
europepmc   +1 more source

The Inverse Association of Psoriasis and Life's Crucial 9 in US Adults: An Analysis from NHANES. [PDF]

J Multidiscip Healthc
Hao JC, Dou DN, Cheng SW, Gou RY.
europepmc   +1 more source

Emergence of Vitiligo during Treatment with Risankizumab-Rzaa for Plaque Psoriasis: A Case Report. [PDF]

Case Rep Dermatol
Thomas KV, Tran JM, Cotter LM.
europepmc   +1 more source

Outcomes in Bimekizumab Treated Psoriasis Patients With Prior IL-17 Inhibitor Failure. [PDF]

J Psoriasis Psoriatic Arthritis
Song EJ, Pretorius P, Dasilva DR, Bunick CG, Liu C, Shahriari M.   +5 more
europepmc   +1 more source